Comparative Pharmacology
Head-to-head clinical analysis: ISOLYTE M IN DEXTROSE 5 IN PLASTIC CONTAINER versus PLASMA LYTE 56 IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: ISOLYTE M IN DEXTROSE 5 IN PLASTIC CONTAINER versus PLASMA LYTE 56 IN PLASTIC CONTAINER.
ISOLYTE M IN DEXTROSE 5% IN PLASTIC CONTAINER vs PLASMA-LYTE 56 IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
ISOLYTE M in Dextrose 5% is a crystalloid solution that provides water, electrolytes, and calories. Dextrose is metabolized to carbon dioxide and water, yielding energy. The electrolytes (sodium, potassium, magnesium, chloride, acetate, and gluconate) maintain or restore intravascular volume and acid-base balance. Acetate and gluconate are bicarbonate precursors, metabolized in the liver and peripheral tissues to generate bicarbonate, thus correcting metabolic acidosis.
PLASMA-LYTE 56 is an isotonic crystalloid solution that provides electrolytes and water to maintain or restore intravascular volume and electrolyte balance. It expands extracellular fluid volume and improves circulation by increasing plasma volume. The solution's electrolyte composition mimics plasma, helping to correct electrolyte deficits and acid-base disturbances.
Intravenous infusion; dose determined by fluid and electrolyte requirements; typical adult rate 100-200 mL/hour.
Intravenous infusion; dose depends on fluid and electrolyte needs; typical adult rate: 100-200 mL/hour.
None Documented
None Documented
No true terminal half-life; infused components (water and electrolytes) follow endogenous kinetics. Dextrose half-life approx. 1-2 hours, electrolytes distribute and are excreted based on renal function.
Not applicable as a fixed value; infused electrolytes distribute and are eliminated according to individual ion kinetics (e.g., sodium t½ ~30 min, chloride t½ ~1–2 h) with rapid redistribution.
Primarily renal; >90% of infused water and electrolytes are excreted unchanged via kidneys with minimal biliary or fecal elimination.
Primarily renal; >90% of infused electrolytes are excreted unchanged in urine; fecal elimination negligible (<5%).
Category C
Category C
Intravenous Electrolyte Solution
Intravenous Electrolyte Solution